Maury Raycroft

Stock Analyst at Jefferies

(0)
# 4829
Out of 5,298 analysts
78
Total ratings
13.51%
Success rate
-28.78%
Average return
Main Sectors:
Top Industries:
41 Stocks
Name Action Price Target Current % Upside Ratings Updated
CRBP Corbus Pharmaceutica...
Maintains: Buy
70 53
4.9 981.63% 2 Mar 11, 2025
CMRX Chimerix
Downgrades: Hold
10 9
8.53 -0.35% 2 Mar 5, 2025
CMPX Compass Therapeutics
Maintains: Strong Buy
7 8
1.47 444.22% 2 Feb 10, 2025
SGMO Sangamo Therapeutics
Maintains: Buy
7 3
0.65 361.54% 1 Dec 31, 2024
MREO Mereo BioPharma Grou...
Initiates Coverage On: Buy
7
1.96 257.14% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.11 440.54% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Strong Buy
16 17
0.81 1998.77% 1 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
1.25 1420% 1 Jul 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
58 39
n/a n/a 2 May 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
23 15
1.48 913.51% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 39
15.54 150.97% 2 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.67 795.52% 1 Mar 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.38 1566.67% 1 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
0.62 2319.35% 1 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 58
n/a n/a 7 Oct 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
11
6.85 60.58% 8 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
104 173
n/a n/a 3 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4 2
n/a n/a 1 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
6 9
0.32 2712.5% 2 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32 6
21.04 -71.48% 2 Jan 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 75
10.81 593.8% 4 Nov 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 36
n/a n/a 2 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
218 232
243.15 -4.59% 1 Oct 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
2.52 336.51% 1 Sep 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 20
n/a n/a 1 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
39 55
n/a n/a 1 Apr 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
31 27
7.72 249.74% 3 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
38 5
1.46 242.47% 2 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 17
n/a n/a 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Nov 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
8.02 498.5% 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
n/a n/a 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
5.87 513.29% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
105
3.21 3171.03% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
172
32.16 434.83% 2 Apr 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
n/a n/a 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
47
1.37 3330.66% 1 Feb 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 2
n/a n/a 2 Jan 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
18 40
0.57 6917.54% 5 Aug 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
230
3.77 6000.8% 1 Jul 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 42
6.5 546.15% 3 Nov 1, 2017